Sound like a successful strategy of any business but I think the initial lowball offer was because Pfizer didn't know how to value the company. However, I was surprised they didn't just increase this to the IER's prefer valuation without the Data Confirmation caveat which made the market question whether they really wanted the technology causing some very LT to even sell but since they eventually got here it's clearly they do.......
- Forums
- ASX - By Stock
- RAP
- Valuing ResApp Health
Valuing ResApp Health, page-385
-
- There are more pages in this discussion • 82 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RAP (ASX) Chart |
Day chart unavailable